10th International Congress of the Immunology of Diabetes Society in Malm?,Sweden

第十届国际糖尿病学会免疫学大会在瑞典马尔姆举行

• 批准号: 7672586
• 负责人: AKE LERNMARK
• 金额: $ 2万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2010-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7672586
• 关键词: Address; Affect; Archives; Arts; Autoimmune Process; Autoimmunity; Belief; Beta Cell; Biological Assay; Blood Vessels; Centers for Disease Control and Prevention (U.S.); Child; Chronic Disease; Communities; Congresses; Diabetes Mellitus; Diabetes autoantibodies; Disease; Educational workshop; Etiology; Funding; Genetic; Grant; Immunology; Incidence; Individual; Injection of therapeutic agent; Insulin; Insulin-Dependent Diabetes Mellitus; International; Internet; Islets of Langerhans; Kidney; Life; Nerve; Oral; Pathogenesis; Patients; Preventive Intervention; Research; Research Personnel; Rest; Retina; Risk; Scholarship; Scientist; Societies; Standardization; Stream; Sweden; T-Lymphocyte; Time; Travel; United States National Institutes of Health; abstracting; lectures; meetings; posters; programs; symposium; web site

DESCRIPTION (provided by applicant): As the founding President of the Immunology of Diabetes Society and current co-chair of the Organizing Committee, Dr. Lernmark is submitting a grant to the National Institutes of Health for meeting support of the 10th International Congress of the Immunology of Diabetes Society (IDS) to be held in Malmoe, Sweden between Wednesday May 13 and Saturday May 16, 2009. This is a 3.5 day meeting that we expect to be attended by approximately 400 delegates from all over the world. The IDS is an international forum from all aspects of autoimmune type 1 diabetes - etiology- both genetic and environmental, pathogenesis, prediction, prevention, intervention and cure. International meetings are held under the IDS' auspice every 1.5 years. The last meeting was in Miami, FL in November, 2007. For this next meeting we are focusing on presenting recent advances in type 1 diabetes through key note address presentations, Symposia, Hot Topics, Debates, Oral presentations (10 min and 5 min discussion) and poster presentations the state of the art information within related fields. Oral presentations will be selected from submitted abstracts. There will be two workshops - one presenting results from the Diabetes Autoantibody Standardization Program (DASP) supported by the CDC and NIH and another about T cell Assay Standardization. The belief is that the diabetes immunology community will benefit much by sharing of information in the newest advances of other fields of research in immunology, genetics and autoimmunity. Hence the Key Address speakers are leading scientist in these fields of research. The organizing committee is planning to broadcast the lectures and presentations live on the internet. These lectures and presentations will also be archived and available on the conference website for a limited period of time streaming audio and on CD. More than half of the grant will be used to provide travel scholarships to young investigators. Travel grants for young investigators will be chosen by numerical ratings of submitted abstracts. Additional travel funding will be applied to Key Note address speakers, symposia speakers of Hot topics speakers chosen by the international organizing committee as outlined in the preliminary program. Type 1 diabetes, caused by an autoimmune attack on the pancreatic islet beta cells is the most common chronic disease in children. The incidence is increasing world-wide. There is no cure of type 1 diabetes and patients are dependent on daily insulin injections for the rest of their life-time. Every patients suffer the risk of late complications affecting the blood vessels, retina, kidney and nerves. It is a very expensive disease for the individual patient and for society.

描述（由申请人提供）：作为糖尿病免疫学协会的创始主席和现任组织委员会联合主席，Lernmark 博士正在向美国国立卫生研究院提交一笔拨款，用于支持第十届国际糖尿病协会大会糖尿病协会免疫学 (IDS) 将于 2009 年 5 月 13 日星期三至 5 月 16 日星期六在瑞典马尔默举行。这是一个为期 3.5 天的会议，我们预计将参加由来自世界各地的约 400 名代表组成。 IDS 是一个涵盖自身免疫 1 型糖尿病（病因学、遗传和环境、发病机制、预测、预防、干预和治疗）各个方面的国际论坛。 IDS 每 1.5 年主办一次国际会议。上一次会议于 2007 年 11 月在佛罗里达州迈阿密举行。对于下一次会议，我们将重点通过主题演讲、座谈会、热门话题、辩论、口头报告（10 分钟和 5 分钟讨论）介绍 1 型糖尿病的最新进展）和海报展示了相关领域的最新信息。口头报告将从提交的摘要中选出。将举办两场研讨会，一场介绍 CDC 和 NIH 支持的糖尿病自身抗体标准化计划 (DASP) 的结果，另一场则介绍 T 细胞检测标准化。人们相信，糖尿病免疫学界将通过分享免疫学、遗传学和自身免疫等其他研究领域的最新进展信息而受益匪浅。因此，主旨演讲者都是这些研究领域的顶尖科学家。组委会计划在互联网上直播讲座和演示。这些讲座和演示文稿也将在会议网站上存档并在有限时间内以流媒体音频和 CD 形式提供。一半以上的补助金将用于为年轻研究人员提供旅行奖学金。年轻研究者的旅费补助将根据提交摘要的数字评级来选择。额外的差旅费将用于国际组委会根据初步计划选出的主旨演讲嘉宾、专题讨论会演讲嘉宾和热点话题演讲嘉宾。 1 型糖尿病是由自身免疫攻击胰岛 β 细胞引起的，是儿童中最常见的慢性疾病。全世界的发病率正在增加。 1 型糖尿病无法治愈，患者余生都依赖每日注射胰岛素。每个患者都面临着影响血管、视网膜、肾脏和神经的晚期并发症的风险。对于个体患者和社会来说，这是一种非常昂贵的疾病。